TABLE 3.
Women (n = 8477) |
Men (n = 6507) |
|||
---|---|---|---|---|
Variables | OR (95% CI) | P | OR (95% CI) | P |
| ||||
Age (per year) | 0.98 (0.97–0.99) | <0.001 | 1.00 (0.99–1.01) | 0.998 |
Education (ref ≤ 12 years education) | 1.03 (0.93–1.14) | 0.609 | 1.39 (1.26–1.54) | <0.001 |
Country (ref Aus) | 2.04 (1.71–2.44) | <0.001 | 1.89 (1.55–2.31) | <0.001 |
Living situation (ref living alone) | 0.83 (0.76–0.91) | <0.001 | 0.92 (0.82–1.03) | 0.158 |
Polypharmacy | 1.30(1.16–1.46) | <0.001 | 1.14 (1.01–1.29) | 0.033 |
Diabetes | 0.70 (0.60–0.81) | <0.001 | 0.97 (0.85–1.11) | 0.656 |
Dyslipidemia | 0.88 (0.75–1.02) | 0.097 | 1.14 (1.01–1.27) | 0.029 |
Frailty | 1.10(1.02–1.18) | 0.016 | 1.04 (0.96–1.13) | 0.331 |
Development of MACE in-trialb | 0.60 (0.43–0.83) | 0.002 | 0.78 (0.60–1.02) | 0.072 |
Abbreviations: CI, confidence interval; OR, odds ratio.
Multivariate regression analysis stratified by sex. Values given as adjusted odds ratios (95% CI).
MACE: major adverse cardiovascular events including nonfatal myocardial infarction and fatal or nonfatal ischemic stroke.